Please check your internet connection and try again.
# Clobazam (Oral Formulation)
## Overview
Clobazam is a benzodiazepine derivative with anticonvulsant properties. It is used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS).
## Primary Indications
Adjunctive treatment of seizures in patients 2 years of age and older with Lennox-Gastaut syndrome (LGS).
## Adult Dosing
* **Initial Dose:** 5 mg orally twice daily.
* **Titration:** Increase dose every week based on clinical response and tolerability.
* **Maintenance Dose:** Typically 10 mg to 20 mg orally twice daily.
* **Maximum Dose:** 20 mg orally twice daily (40 mg/day).
## Pediatric Dosing (2 years and older)
* **Initial Dose:** 5 mg orally twice daily.
* **Titration:** Increase dose every week based on clinical response and tolerability.
* **Maintenance Dose:** Typically 10 mg to 20 mg orally twice daily.
* **Maximum Dose:** 20 mg orally twice daily (40 mg/day).
* **Note:** Dosing for children under 2 years of age is not well-established and requires extreme caution.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Consider lower doses.
* **Renal Impairment:** Use with caution. Consider lower doses.
* **Concomitant Medications:** Clobazam is a CYP2C19 substrate and inhibitor. Consider interactions, particularly with drugs that are also CYP2C19 substrates or inhibitors (e.g., omeprazole, clopidogrel).
## Contraindications
* Hypersensitivity to clobazam or any component of the formulation.
* Severe respiratory impairment.
* Severe hepatic impairment.
* Acute narrow-angle glaucoma.
## Adverse Effects
* **Common:** Somnolence, decreased appetite, constipation, fatigue, aggression, irritability, vomiting, ataxia, drooling, upper respiratory tract infection, pneumonia.
* **Serious:** Suicidal behavior and ideation, respiratory depression, dependence and withdrawal symptoms, severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis).
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, other benzodiazepines, sedating antihistamines):** Increased risk of sedation, respiratory depression, and coma.
* **CYP2C19 Inhibitors (e.g., fluconazole, fluvoxamine):** May increase clobazam concentrations.
* **CYP2C19 Inducers (e.g., rifampin, carbamazepine):** May decrease clobazam concentrations.
* **Antiepileptic Drugs (AEDs):** Clobazam can affect levels of other AEDs (e.g., valproate, stiripentol). Monitor AED levels and for toxicity. Stiripentol increases clobazam levels.
## Monitoring
* Monitor for signs of somnolence, sedation, and respiratory depression, especially with initiation or dose increases.
* Monitor for worsening depression, suicidal thoughts or behavior, and unusual changes in behavior.
* Monitor for signs of drug dependence and withdrawal.
* Regularly assess seizure frequency and severity.
* Monitor for potential drug interactions, especially with concomitant anticonvulsants.
## Clinical Pearls
* Clobazam is typically used as adjunctive therapy for LGS.
* Slow titration is recommended to minimize adverse effects.
* Patients should be advised against driving or operating heavy machinery until they know how clobazam affects them.
* Abrupt discontinuation should be avoided due to potential withdrawal symptoms. Tapering is recommended.
***
**Disclaimer:** This information is intended for clinical decision-making and does not replace the need to consult the official prescribing information and local protocols. Always verify current dosing and safety information with the most up-to-date resources.
